OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM)

CUSIP: 75974E103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
12,657,935
Total 13F shares
17,292,271
Share change
-120,094
Total reported value
$50,816,704
Price per share
$2.94
Number of holders
39
Value change
-$725,499
Number of buys
12
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 75974E103?
CUSIP 75974E103 identifies RPHM - OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM) as of Q1 2022

As of 31 Mar 2022, OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,292,271 shares. The largest 10 holders included NEA Management Company, LLC, Novo Holdings A/S, RiverVest Venture Management LLC, Abingworth LLP, Rock Springs Capital Management LP, Aisling Capital Management LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, and BlackRock Inc.. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.